RxDoctor Payments Data

Jennifer Doty

Physician Assistant · Missoula, MTNPI 1295183994

Payments from drug & device makers

What this record shows

6 manufacturers reported payments, led by Livanova USA, Inc. at 34.8% of the total. Among physician assistant clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,885in general payments, 2019–2025

Across 112 payments — averaging $52.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$2K
  • Boston Scientific$2K
  • AbbVie$2K
  • Bristol Myers Squibb$153
  • TG Therapeutics, Inc.$82
  • Amneal Pharmaceuticals LLC$11

What the payments were for

  • Travel & lodging$3,22255%
  • Food & beverage$2,66245%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,885 in reported general payments places this provider in the 95th percentile of 626 physician assistant providers in Montana.

See all physician assistant providers in Montana

Medicare billing

Part B allowed, 2024
$137,384
Medicare patients
235
Services billed
12,003

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CopaxoneGlatiramer Acetate37$204,578
Avonex (4 Pack)Interferon Beta-1a14$106,669
RytaryCarbidopa/Levodopa51$75,430
GlatopaGlatiramer Acetate21$47,580
Emgality PenGalcanezumab-Gnlm40$34,667
UbrelvyUbrogepant20$26,470
NayzilamMidazolam12$23,550
Aimovig AutoinjectorErenumab-Aooe23$16,588
Dalfampridine ErDalfampridine43$13,365
Leucovorin Calcium13$11,250
Carbidopa-LevodopaCarbidopa/Levodopa320$9,769
Ajovy AutoinjectorFremanezumab-Vfrm12$8,457
Levetiracetam179$6,255
Entacapone14$5,268
LamictalLamotrigine13$3,568

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCRytary$11$75,43051 claims
AbbVieUbrelvy$1,728$26,47020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 626 physician assistant providers in Montana.

Other physician assistant in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →